Analysis of drug action on tumor cell metabolism using electronic sensor chips

Angela M Otto1, Martin Brischwein, Elena Motrescu

  • 1Heinz-Nixdorf-Chair for Medical Electronics, Technical University of Munich, Munich, Germany. otto@tum.de

Archiv Der Pharmazie
|December 15, 2004
PubMed

Insights

Multiparametric sensor chips monitor real-time changes in tumor cell metabolism, including acidification and oxygen consumption. This system reveals distinct real-time effects of chemotherapeutic drugs like chloroacetaldehyde and cisplatin on cancer cell metabolism.

Area of Science:

  • Biomedical Engineering
  • Cancer Research
  • Cellular Metabolism

Background:

  • Chemotherapeutic drugs significantly impact tumor cell metabolism, affecting key parameters like acid extrusion and oxygen consumption.
  • Real-time analysis of these metabolic changes in living cells is crucial for understanding drug mechanisms.

Purpose of the Study:

  • To develop and validate a novel multiparametric sensor chip system for real-time monitoring of tumor cell metabolism.
  • To investigate the effects of specific chemotherapeutic agents on cancer cell metabolic activity.

Main Methods:

  • Development of a microfluidic chip system with integrated sensors for real-time monitoring of pH, oxygen (O(2)), and electric impedance.
  • Cultivation of human colon carcinoma LS174T cells on the sensor chips under microphysiological conditions.
  • Real-time measurement of cellular acidification and respiration rates following drug administration.

Main Results:

  • Untreated LS174T cells exhibited a consistent increase in acidification rate and a stable respiration rate.
  • Chloroacetaldehyde (50 µM) rapidly reduced oxygen consumption and subsequently decreased acidification.
  • Cisplatin (16.7 µM) induced a delayed, gradual decrease in both acidification and respiration rates over 2-3 days.

Conclusions:

  • Multiparametric sensor chips offer a powerful tool for real-time, in-depth analysis of chemotherapeutic drug effects on cancer cell metabolism.
  • The observed distinct metabolic responses to chloroacetaldehyde and cisplatin align with known drug mechanisms, validating the system's utility.
  • This technology provides fundamental insights into drug action, aiding in the development and evaluation of cancer therapies.